Skip to content

The Application of mixed reality to sentinel lymph node biopsy in breast cancer running title: application of mixed reality in breast cancer

The Application of mixed reality to sentinel lymph node biopsy in breast cancer running title: application of mixed reality in breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042018
Enrollment
Unknown
Registered
2021-01-12
Start date
2018-08-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

The control group received routine operation:Routine biopsy
Experimental group of hybrid reality technology:Biopsy with three-dimensional reconstruction technique

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral primary breast cancer; 2. The size of tumor was in clinical stage I ~ II; 3. All patients were confirmed as breast cancer by puncture before operation; 4. Subjects with no significant abnormal axillary lymph nodes were evaluated by preoperative imaging; 5. Informed consent of patients and their families.

Exclusion criteria

Exclusion criteria: 1. Subjects with history of axillary surgery on the affected side; 2. Patients who do not agree to accept breast conserving surgery or any anti-tumor treatment or preventive treatment before surgery.

Design outcomes

Primary

MeasureTime frame
Operation time;

Secondary

MeasureTime frame
Incidence of adverse events;

Countries

China

Contacts

Public ContactChen Xi

The Second Affiliated Hospital of Harbin Medical University

13804517666@163.com+86 13804517666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026